Renal Dehydropeptidase Inhibitor class drugs

1 result
  • recarbrio

    (imipenem anhydrous, cilastatin, and relebactam anhydrous)
    Merck Sharp & Dohme LLC
    RECARBRIO is indicated for treating adults with hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, complicated urinary tract infections, and complicated intra-abdominal infections caused by specific susceptible gram-negative bacteria, particularly when limited treatment options exist. Its use aims to combat drug-resistant bacterial development.